These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32990946)

  • 21. Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions.
    Chandler RE
    Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):389-395. PubMed ID: 30556617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.
    Almenoff JS; LaCroix KK; Yuen NA; Fram D; DuMouchel W
    Drug Saf; 2006; 29(10):875-87. PubMed ID: 16970511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.
    Caster O; Sandberg L; Bergvall T; Watson S; Norén GN
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):1006-1010. PubMed ID: 28653790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
    Johnson K; Guo C; Gosink M; Wang V; Hauben M
    Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions.
    Ahmed I; Pariente A; Tubert-Bitter P
    Stat Methods Med Res; 2018 Mar; 27(3):785-797. PubMed ID: 27114328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.
    Roux E; Thiessard F; Fourrier A; Bégaud B; Tubert-Bitter P
    IEEE Trans Inf Technol Biomed; 2005 Dec; 9(4):518-27. PubMed ID: 16379369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
    Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A conceptual approach to the masking effect of measures of disproportionality.
    Maignen F; Hauben M; Hung E; Holle LV; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):208-17. PubMed ID: 24243699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database.
    Dodd C; Pacurariu A; Osokogu OU; Weibel D; Ferrajolo C; Vo DH; Becker B; Kors JA; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1249-1256. PubMed ID: 30066460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database.
    Courtois É; Pariente A; Salvo F; Volatier É; Tubert-Bitter P; Ahmed I
    Front Pharmacol; 2018; 9():1010. PubMed ID: 30279658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.
    Lee I; Jokinen JD; Crawford SY; Calip GS; Kilpatrick RD; Lee TA
    Ther Innov Regul Sci; 2021 Jan; 55(1):142-151. PubMed ID: 32720297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.
    Monaco L; Melis M; Biagi C; Donati M; Sapigni E; Vaccheri A; Motola D
    Expert Opin Drug Saf; 2017 Mar; 16(3):271-275. PubMed ID: 28094583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in Pharmacovigilance.
    Hui TZ
    Curr Drug Saf; 2020; 15(2):124-130. PubMed ID: 32091345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A shrinkage-based comparative assessment of observed-to-expected disproportionality measures.
    Gipson G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):589-96. PubMed ID: 22290739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.